Artículos por temáticas

A review of the application of exercise intervention on improving cognition in patients with Alzheimer's disease: mechanisms and clinical studies

Wang M, Hua Y, Bai Y.

Rev Neurosci. 2024 Jul 22;36(1):1-25. doi: 10.1515/revneuro-2024-0046. Print 2025 Jan 29.

Drawing a line?-Visuo-constructive function as discriminator between healthy individuals, subjective cognitive decline, mild cognitive impairment and Alzheimer's disease and predictor of disease progress compared to a multimodal approach

Tokaj A, Lehrner J.

Neuropsychiatr. 2024 Jun;38(2):71-81. doi: 10.1007/s40211-022-00455-8. Epub 2023 Feb 1.

CT perfusion appearance of CADASIL coma

Merli E, Zini A, Gentile M.

Acta Neurol Belg. 2024 Jun;124(3):1005-1007. doi: 10.1007/s13760-022-02017-9. Epub 2022 Jul 13.

Sensory Loss and Risk of Dementia

Lad M, Sedley W, Griffiths TD.

Neuroscientist. 2024 Apr;30(2):247-259. doi: 10.1177/10738584221126090. Epub 2022 Sep 28.

Impaired performances on the category cued memory test in mild Alzheimer's disease and dementia with Lewy bodies: A comparative validity study

Vogel A, Mellergaard C, Waldemar G, Frederiksen KS.

Appl Neuropsychol Adult. 2024 Jul-Aug;31(4):323-328. doi: 10.1080/23279095.2021.2021413. Epub 2021 Dec 27.

Atrial fibrillation and the risk of early-onset dementia and cognitive decline: An updated review

Kogelschatz B, Zenger B, Steinberg BA, Ranjan R, Jared Bunch T.

Trends Cardiovasc Med. 2024 May;34(4):236-241. doi: 10.1016/j.tcm.2023.01.005. Epub 2023 Jan 24.

Intelligent assistive technology devices for persons with dementia: A scoping review

Dada S, van der Walt C, May AA, Murray J.

Assist Technol. 2024 Sep;36(5):338-351. doi: 10.1080/10400435.2021.1992540. Epub 2022 Jan 25.

Anesthesia and dementia: An up-to-date review of the existing literature

Tsolaki M, Sia E, Giannouli V.

Appl Neuropsychol Adult. 2024 Mar-Apr;31(2):181-190. doi: 10.1080/23279095.2022.2110871. Epub 2022 Aug 18.

Study rationale and baseline data for pilot trial of dronabinol adjunctive treatment of agitation in Alzheimer's dementia (THC-AD)

Cohen LM, Ash E, Outen JD, Vandrey R, Amjad H, Agronin M, Burhanullah MH, Walsh P, Wilkins JM, Leoutsakos JM, Nowrangi MA, Harper D, Rosenberg PB, Forester BP.

Int Psychogeriatr. 2024 Dec;36(12):1245-1250. doi: 10.1017/S1041610221001150. Epub 2021 Oct 11.

The CORCOBIA study: Cut-off points of Alzheimer's disease CSF biomarkers in a clinical cohort

Puig-Pijoan A, García-Escobar G, Fernández-Lebrero A, Manero-Borràs RM, Sánchez-Benavides G, Navalpotro-Gómez I, Cascales Lahoz D, Suárez-Calvet M, Grau-Rivera O, Boltes Alandí A, Pont-Sunyer MC, Orti

Neurologia (Engl Ed). 2024 Nov-Dec;39(9):756-765. doi: 10.1016/j.nrleng.2022.05.002. Epub 2022 Aug 9.

Naming as a window to word retrieval changes in healthy and pathological ageing: Methodological considerations

Martínez-Ferreiro S.

Int J Lang Commun Disord. 2024 Jan-Feb;59(1):68-83. doi: 10.1111/1460-6984.12827. Epub 2022 Dec 12.

The risk of dementia or cognitive impairment in patients with cataracts: a systematic review and meta-analysis

Wang L, Sang B, Zheng Z.

Aging Ment Health. 2024 Jan-Feb;28(1):11-22. doi: 10.1080/13607863.2023.2226616. Epub 2023 Jul 7.

Anti-amyloid antibody treatments for Alzheimer's disease

Perneczky R, Dom G, Chan A, Falkai P, Bassetti C.

Eur J Neurol. 2024 Feb;31(2):e16049. doi: 10.1111/ene.16049. Epub 2023 Sep 11.

COVID-19 and the impact on Alzheimer's disease pathology

Furman S, Green K, Lane TE.

J Neurochem. 2024 Oct;168(10):3415-3429. doi: 10.1111/jnc.15985. Epub 2023 Oct 18.

Is headache a risk factor for dementia? A systematic review and meta-analysis

Cermelli A, Roveta F, Giorgis L, Boschi S, Grassini A, Ferrandes F, Lombardo C, Marcinnò A, Rubino E, Rainero I.

Neurol Sci. 2024 Mar;45(3):1017-1030. doi: 10.1007/s10072-023-07069-0. Epub 2023 Sep 18.